Sunlenca Product Label
Interaction Color Code
Clinical Bottom Line
Minimal data to guide interaction: risks likely to outweigh benefits
Drug 1
Drug 2
Mechanism
Inhibition of CYP3A4 by lenacapavir
Clinical Effects
Increased risk of naloxegol adverse effects
Management
Consider using alternative agents. If coadministration is unavoidable, decrease dose of naloxegol and monitor for adverse reactions.
Info Source
